Trial to evaluate the efficacy of fluvastatin on certain markers
Phase of Trial: Phase IV
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Fluvastatin (Primary)
- Indications Dyslipidaemias
- Focus Biomarker; Pharmacodynamics
- Sponsors Novartis
- 07 Nov 2011 Actual end date (1 Jun 2007) added as reported by ClinicalTrials.gov.
- 21 Apr 2008 New trial record.